Please use this identifier to cite or link to this item:
|Title:||Evaluation of new naphthalimides as potential anticancer agents against breast cancer MCF-7, pancreatic cancer BxPC-3 and colon cancer HCT- 15 cell lines|
|Author(s):||Noro, Jennifer Martins|
Olival, A. C. D.
Silva, A. C. D.
Alves, Maria José Chão
Kong, Thoo Lin
|Journal:||Organic Chemistry: Current Research|
|Citation:||Noro J, Maciel J, Duarte D, Olival ACD, Baptista C, et al. (2015) Evaluation of New Naphthalimides as Potential Anticancer Agents against Breast Cancer MCF-7, Pancreatic Cancer BxPC-3 and Colon Cancer HCT-15 Cell Lines. Organic Chem Curr Res 4: 144. doi:10.4172/21610401.1000144|
|Abstract(s):||New 1,8-naphthalimido derivatives with 2,3 and 4 carbon chains bearing a number of different functionalities were synthesized and tested against a panel of breast cancer MCF-7, colon cancer HCT-15 and pancreatic cancer BxPC-3 cell lines. Generally structures with shorter alkyl chains were more active, with the one exception of the amide containing a p-nitrophenyl group. GI50 values (µM) were determined for the most active compounds. Three compounds exhibited GI50 values below 5 µM, two with MCF-7 cells, and one other with HCT-15. Compounds with different functionalities demonstrated cell line specificity: the MCF-7 cell line was more sensitive to an urea derivative (6f), the growth of HCT15 cells were most affected by a triazole (9d), while the BxPC-3 cell line was inhibited in a higher extend by a guanidine (4a).|
|Access:||Restricted access (Author)|
|Appears in Collections:||CDQuim - Artigos (Papers)|
Files in This Item:
|Organic Chemistry. current research.pdf|
|985,2 kB||Adobe PDF||View/Open Request a copy!|